Related by context. All words. (Click for frequent words.) 79 ThermoDox ® 74 ThermoDox R 67 Azedra 65 RCW breast cancer 65 pertuzumab 64 CoFactor 64 HGS# 64 axitinib 63 Cotara 63 HuMax EGFr 63 IMA# 63 tanespimycin 63 Imprime PGG 63 REOLYSIN ® 62 radiation sensitizer 62 Ceflatonin 62 vascular disrupting agent 62 sorafenib Nexavar ® 62 Delcath PHP System 62 liposomal doxorubicin 62 obatoclax 62 Proxinium TM 62 OncoVEX GM CSF 62 eniluracil 62 CBLC# 61 ixabepilone 61 BrachySil TM 61 EOquin TM 61 PXD# 61 NP2 Enkephalin 61 oral ridaforolimus 61 ELACYT 61 CA4P 61 CINQUIL 61 drug eluting stent DES 61 Bezielle 61 amrubicin 61 phase IIa clinical 61 relapsed refractory multiple myeloma 61 T DM1 61 mapatumumab 60 perifosine 60 Amplimexon 60 Combo Stent 60 YONDELIS 60 Neuradiab 60 BrachySil 60 sorafenib tablets 60 romidepsin 60 neratinib 60 CLORETAZINE TM VNP#M 60 MGd 60 alvespimycin 60 Archexin 60 hyperthermia therapy 60 vorinostat 60 MEK inhibitor RDEA# 60 Alpharadin 60 PFO closure 60 IMGN# 60 microwave hyperthermia 60 Azixa 60 phase IIb clinical 60 Onrigin 60 Nexavar ® 60 Myocet 60 Phase Ib study 60 sorafenib Nexavar 60 capecitabine Xeloda R 60 pralatrexate 59 ospemifene 59 BRAF inhibitor 59 liposomal formulation 59 farletuzumab 59 PROSTVAC TM 59 TAXUS Liberte Stent 59 talactoferrin 59 IIa trial 59 palifosfamide 59 SIR Spheres 59 Tyrima 59 Hsp# inhibitor 59 FOLOTYN ® 59 afatinib 59 registrational trial 59 Exelixis compounds 59 ganetespib 59 Orazol 59 Aplidin 59 sapacitabine 59 trabectedin 59 enzastaurin 59 deforolimus 59 trodusquemine 59 Nanobody 59 gemcitabine chemotherapy 59 oral deforolimus 59 bevacizumab Avastin 59 Intravenous CP 59 relapsed multiple myeloma 59 randomized Phase III 59 FOLFOX6 chemotherapy regimen 59 HER2 positive metastatic breast 59 relapsing multiple sclerosis 59 Toraymyxin TM 59 AP# [003] 59 Chemophase 59 AeroLEF TM 59 anticancer agent 59 zalutumumab 59 FOLOTYN 59 nab paclitaxel 59 phase Ib 59 forodesine 59 evaluating tivozanib 59 TREANDA 59 Phase 1b trial 59 paclitaxel poliglumex 59 OMNARIS HFA 59 CardioFit 59 Allovectin 7 ® 58 pomalidomide 58 IRX 2 58 QuadraSphere 58 OncoGel 58 Amrubicin 58 XIENCE V 58 PrevOnco ™ 58 Anavex #-# 58 Gefitinib 58 Exherin TM 58 Tarceva TM 58 NEVO TM 58 CR# vcMMAE 58 chemotherapeutic drug 58 GALNS 58 picoplatin 58 OHR/AVR# 58 RE LY 58 ozarelix 58 MEND CABG II 58 Doxil 58 MAGE A3 ASCI 58 Sym# 58 SUCCEED trial 58 NeuroFlo 58 bevacizumab Avastin ® 58 Reolysin 58 SNT MC# 58 DP b# 58 docetaxel Taxotere R 58 TTF Therapy 58 regorafenib 58 vandetanib 58 AZILECT ® 58 INCB# [001] 58 OXi# 58 Pertuzumab 58 MGN# 58 oral anticoagulant 58 PHX# 58 tezampanel 58 Restanza 58 Abiraterone acetate 58 HGS ETR1 58 Allovectin 7 58 tesetaxel 58 TORISEL 58 Aflibercept 58 XmAb# 58 TAXUS Element Paclitaxel Eluting 58 Catena ® 58 Ixempra 58 ponatinib 58 Vicinium TM 58 Icatibant 58 metaglidasen 58 teriflunomide 58 ADVEXIN 58 standard chemotherapy regimen 58 velafermin belinostat 58 PI3K/Akt pathway inhibitor 58 randomized Phase 58 PF # [001] 58 Ophena TM 58 ZYBRESTAT 58 Viprinex 57 MDV# 57 tesmilifene 57 sulodexide 57 Aliskiren 57 Pirfenidone 57 GAP #B# 57 PROMUS Element Stent 57 novel oral anticoagulant 57 stereotactic body 57 Ketotransdel 57 NEVO ™ 57 EFAPROXYN 57 Anthim 57 Traficet EN 57 StemEx R 57 Telavancin 57 tocilizumab 57 ZOLINZA 57 elotuzumab 57 Panzem R NCD 57 CIMZIA TM 57 Phase #b/#a clinical 57 efficacy tolerability 57 LBH# 57 docetaxel chemotherapy 57 PEG SN# 57 anticancer compound 57 Quinamed 57 MicroThermX 57 Serdaxin 57 Dapagliflozin 57 neoadjuvant 57 KRN# 57 Tryton Side Branch 57 phase IIb 57 immunotherapeutic vaccine 57 BRIM2 57 targeted radiotherapeutic 57 custirsen 57 ARIKACE 57 doxorubicin Transdrug ® 57 vidofludimus 57 reslizumab 57 Zerenex 57 elacytarabine 57 riociguat 57 Xcytrin 57 Revimmune 57 angiogenesis inhibitor 57 histone deacetylase HDAC inhibitor 57 fosbretabulin 57 ACTEMRA TM 57 Virulizin ® 57 pharmacokinetic PK 57 torezolid phosphate 57 dose escalation trial 57 Atiprimod 57 Litx 57 Telatinib 57 Ceplene/IL-2 57 Perifosine 57 cediranib 57 Tamibarotene 57 Irinotecan 57 Tectin TM 57 thymalfasin 57 bortezomib Velcade ® 57 Cloretazine R VNP#M 57 Jevtana 57 Cloretazine 57 dabigatran etexilate 57 thermal ablation 57 APPRAISE 57 Panzem R 57 ProLindac 57 Annamycin 57 oral prodrug 57 ongoing Phase 1b 57 CRLX# 57 Resolute DES 57 ASA# 57 placebo controlled clinical 57 metastatic renal cell carcinoma 57 palifosfamide Zymafos TM 57 refractory AML 57 oral picoplatin 57 diabetic neuropathic pain 56 Recurrent Chest Wall 56 OvaRex R 56 Targretin 56 carotid artery stenting 56 Phase III ThermoDox 56 ALN VSP 56 rNAPc2 56 brivaracetam 56 refractory CLL 56 erlotinib Tarceva ® 56 Xanafide 56 favorable pharmacokinetic profile 56 Urocidin 56 AEG# 56 LUX Lung 56 paclitaxel eluting stent 56 multicenter Phase 56 Afatinib 56 Removab 56 anti angiogenic therapy 56 ABSORB trial 56 anticancer therapy 56 Phase 2a 56 entinostat 56 trastuzumab Herceptin R 56 PrevOnco 56 tamibarotene 56 OvaRex ® MAb 56 sunitinib 56 registrational 56 depsipeptide 56 OncoVEX 56 PRECISE 56 Zingo TM 56 Pazopanib 56 decitabine 56 anticancer agents 56 PKC# 56 lintuzumab 56 interferon beta therapy 56 metastatic colorectal 56 Degarelix 56 pain palliation 56 ofatumumab 56 tubulin inhibitor 56 Curaxin CBLC# 56 Herceptin trastuzumab 56 Zemplar Capsules 56 cilengitide 56 R#/MEM # 56 ADAGIO study 56 Electronic Brachytherapy 56 Phase 2a trial 56 Phase 2b clinical 56 Phase Ib II 56 oral taxane 56 pharmacokinetic PK study 56 Gemcitabine 56 CRMD# 56 prospective multicenter 56 histone deacetylase inhibitor 56 Prospective Randomized 56 OPAXIO 56 Revlimid lenalidomide 56 Eluting Coronary Stent System 56 LEVADEX 56 rALLy clinical trial 56 recurrent metastatic ovarian cancer 56 Augment Injectable Bone Graft 56 Phase 1b 56 Phase 2b study 56 Phase 1a clinical 56 carboplatin paclitaxel 56 phase IIb study 56 WavSTAT 56 bortezomib Velcade R 56 sunitinib malate 56 MOZOBIL 56 randomized Phase IIb 56 SUTENT 56 Sapacitabine 56 recurrent GBM 56 PRT# 56 REOLYSIN R 56 PEGylated interferon beta 1a 56 Teysuno 56 aflibercept 56 olaparib 56 Phase #b/#a 56 dacetuzumab 56 Phase #/#a 56 Pyridorin 56 TNFerade 56 RAPAFLO 56 docetaxel Taxotere ® 56 CYT# potent vascular disrupting 56 Phase III HEAT 56 AGGRASTAT ® 56 CCX# 56 Actemra tocilizumab 56 DCVax ® Brain 56 Aztreonam 56 CHARISMA trial 56 EOquin 56 IMC A# 56 Tarvacin TM 56 tivozanib 56 L PPDS 56 Alocrest 56 edoxaban 56 AeroLEF 56 MEK inhibitors 56 microsphere therapy 56 hematologic malignancies 56 indibulin 56 Cloretazine ® 56 biliary tract cancer 56 HGS ETR2 56 gemcitabine Gemzar ® 56 EchoCRT 56 crizotinib PF # 56 metastatic sarcomas 56 Endeavor drug eluting 56 orBec 56 Tanespimycin 56 Hsp# Inhibitor 56 Ceflatonin R 56 docetaxel Taxotere 56 Perforomist ™ Inhalation Solution 56 ASONEP 56 Trofex 56 BEMA TM Fentanyl 55 superficial bladder cancer 55 elagolix 55 MYDICAR ® 55 Aloxi R 55 dose escalation Phase 55 refractory angina 55 Cethrin 55 QTinno TM 55 Edwards SAPIEN valve 55 Diabetic Macular Edema DME 55 Allovectin 7 R 55 Bicifadine 55 Anturol TM 55 Nexavar 55 monoclonal antibody conjugated 55 preclinical efficacy 55 ExTRACT TIMI 55 EndoTAG TM -1 55 Curaxin 55 TheraSphere 55 Elagolix 55 Phase Ib 55 MERLIN TIMI 55 surrogate endpoint 55 biologic therapy 55 lapatinib Tykerb 55 bendamustine 55 ACTEMRA 55 Metastatic Melanoma 55 galiximab 55 Folotyn 55 SUTENT ® 55 Hexvix 55 omega interferon 55 Gemzar ® 55 neoadjuvant treatment 55 oral chemotherapeutic agent 55 ZACTIMA 55 Phase IIa trials 55 methylnaltrexone 55 relapsed ovarian cancer 55 leading oral taxane 55 hepatocellular carcinoma 55 Doxil ® 55 IL# PE#QQR 55 BioNumerik 55 Ventavis 55 bortezomib Velcade 55 Dabigatran etexilate 55 anti angiogenic agents 55 anti EGFR antibody 55 vernakalant hydrochloride 55 BAY #-# 55 RLY# 55 Zolinza 55 cutaneous T cell 55 OZURDEX ® 55 rivaroxaban 55 Cell Pouch System 55 TRO# 55 trastuzumab DM1 55 phase 2a 55 bafetinib 55 DCVax ® 55 Avastin bevacizumab 55 NO# [002] 55 unresectable liver cancer 55 Ophena 55 Romidepsin 55 oral antiviral 55 placebo controlled Phase 55 L MTP PE 55 topical formulation 55 IND submission 55 ILLUMINATE 55 refractory Hodgkin lymphoma 55 Halaven 55 TactiCath 55 pancreatic NET 55 MyVax R 55 mTOR inhibitor 55 refractory multiple myeloma 55 Pixuvri 55 cetuximab Erbitux 55 refractory chronic lymphocytic 55 CoAxia 55 velafermin 55 Phase 2b trial 55 eprotirome 55 cancer immunotherapies 55 PNP inhibitor 55 RE COVER 55 multicenter clinical 55 NEUMUNE 55 ELIQUIS 55 lucinactant 55 Phase #/#a trial 55 Revascor TM 55 receptor tyrosine kinase inhibitor 55 MT# MEDI 55 Amphinex ® 55 neoadjuvant therapy 55 REOLYSIN 55 varespladib 55 sorafenib 55 omacetaxine mepesuccinate 55 temsirolimus 55 Troxatyl 55 Glufosfamide 55 metastatic HRPC 55 non resectable 55 chemoradiotherapy 55 Phase IIb clinical trials 55 Increlex ® 55 AVASTIN 55 satraplatin 55 mertansine 55 Golimumab 55 dalbavancin 55 OMAPRO 55 radiofrequency ablation RFA 55 Intarcia 55 Hycamtin 55 Gliadel Wafer 55 RG# [001] 55 pazopanib 55 KNS # 55 microplasmin 55 Zipsor 55 Fludara ® 55 sodium Injection 55 eBx 55 dose escalation 55 HuMax CD4 55 Aurexis 55 Afinitor 55 ToGA 55 Genz # 55 Zilver PTX 55 Panzem 55 Cotavance 55 DUROS 55 European Sepsis Trial 55 GRN# 55 INC# 55 EDEMA3 trial 55 metastatic melanoma 55 liposome formulations 55 RSD# oral 55 darapladib 55 Vandetanib 55 voclosporin 55 lorvotuzumab mertansine 55 randomized controlled Phase 55 HeartNet 55 gemcitabine carboplatin 55 capecitabine Xeloda 55 Taxotere R 55 DAVANAT 55 TroVax 55 DEEP AF 55 Acute Ischemic Stroke 55 Arikace 55 EVEREST II 55 belinostat 55 CINTREDEKIN BESUDOTOX 55 Clolar ® 55 EGEN 55 refractory metastatic 55 temozolomide 55 DOXIL 55 phase IIb trial 55 pivotal Phase 54 AKT inhibitor 54 Advexin 54 gastrointestinal stromal tumors GIST 54 anti leukemic 54 NVA# 54 trastuzumab DM1 T DM1 54 metastatic castrate resistant 54 talabostat 54 pralatrexate injection 54 Valortim 54 multicenter Phase II 54 ColonRing 54 neoadjuvant chemotherapy 54 plasma kallikrein inhibitor 54 HuMax CD# 54 drug eluting stent 54 ruxolitinib 54 Celator 54 recurrent glioma 54 PSMA ADC 54 PROMACTA 54 resistant ovarian cancer 54 HCV protease inhibitor 54 multicentre randomized 54 hereditary deficiency 54 thrombolytic agents 54 EndoTAGTM 1 54 Ketotransdel TM 54 ENLIGHT 54 ELND# 54 DCVax R 54 Bevacizumab 54 Exherin 54 adecatumumab 54 SCH # 54 EP #R 54 Endeavor stent 54 bazedoxifene 54 oncology therapeutics 54 huC# DM4 54 corticosteroid dexamethasone 54 CORT # 54 ON #.Na 54 SBRT 54 lymphoma CTCL 54 luteinizing hormone releasing 54 VIAdel TM technology 54 Zybrestat 54 refractory acute myeloid 54 investigational compound 54 chemoradiation 54 Anturol 54 Ceflatonin ® 54 oxybutynin gel 54 Luveniq 54 BrachySil ™ 54 Stent System 54 LEUKINE 54 Q#IR 54 Everolimus 54 AEGR 54 Sandostatin LAR Depot 54 Phase 2b 54 Resten NG 54 Trastuzumab 54 BR.# 54 XL# SAR# 54 Octreolin 54 Panzem NCD 54 Clonicel 54 Heparin Bioactive Surface 54 Talabostat 54 Pivotal Phase III 54 VNP#M 54 TARIS 54 cetuximab Erbitux ® 54 clofarabine 54 Phase IIIb clinical 54 EpiCeram 54 thalidomide Thalomid 54 anidulafungin 54 dacarbazine 54 confirmatory Phase III 54 motesanib 54 vemurafenib 54 Guanilib 54 Powerlink System 54 GRN#L 54 Fludara 54 ERBITUX 54 CCR5 mAb 54 ZK EPO 54 Genasense ® 54 advanced hepatocellular carcinoma 54 relapsed SCLC 54 IRESSA 54 eritoran 54 pseudobulbar affect PBA 54 TAFA# 54 isoform selective 54 elesclomol 54 MoxDuo IR 54 esophageal candidiasis 54 MoxDuo 54 Evoltra 54 carfilzomib 54 SIR Spheres microspheres 54 Phenoptin 54 CCR9 antagonist 54 SPIRIT IV 54 ENDEAVOR IV 54 metastatic castration resistant 54 metastatic hormone refractory 54 nimotuzumab 54 DR Cysteamine 54 HspE7 54 TAXUS Liberte stent 54 COMFORT II 54 Phase III pivotal 54 lumiliximab 54 ANYARA 54 bevacizumab 54 Apoptone 54 ASSERT trial 54 azacitidine 54 antitumor effect 54 cortical stimulation 54 CYT# 54 CCX# B 54 Lacosamide 54 nitazoxanide 54 TYKERB 54 cangrelor 54 bicifadine 54 NovaBay Aganocide compounds 54 ELOXATIN 54 adjuvant colon cancer 54 NATRECOR ® 54 PEG PAL 54 L BLP# 54 Carfilzomib 54 ATL# [001] 54 vismodegib 54 FavId 54 multicenter prospective 54 FOLFIRI chemotherapy 54 Actemra 54 NGX# 54 refractory PTCL 54 Endeavor DES 54 EVIZON 54 CYPHER ® Stent 54 prasugrel Effient 54 ZADAXIN 54 JAK inhibitor 54 antiplatelet agent 54 XIENCE V stent 54 Dacogen injection 54 radiation therapy SBRT 54 XL# [003] 54 Lymphoseek 54 DU #b 54 double blinded placebo 54 Aptocine 54 REVLIMID 54 Phase #b/#a trial 54 Zelrix 54 Vascugel 54 active comparator 54 CANCIDAS 54 granisetron 54 SABCS 54 Tryton stent 54 APOPTONE 54 Bioral Amphotericin B 54 prospective multicenter randomized 54 paclitaxel Taxol ® 54 EDEMA3 54 HER2 positive breast cancer 54 randomized discontinuation trial 54 GTC recombinant human 54 recurrent ovarian cancer 54 multicenter Phase III 54 eltrombopag 54 Hepatocellular Carcinoma HCC 54 Vivaglobin 54 CBLB# 54 oral formulation 54 Pafuramidine 54 AzaSite Plus 54 SinuNase 54 AS# amonafide L malate 54 docetaxel 54 Lenocta 54 PREOS 54 irinotecan chemotherapy 54 iniparib 54 everolimus eluting stent 54 ZYBRESTAT fosbretabulin 54 inhaled iloprost 54 Vilazodone 54 Rexin G 54 recurrent NSCLC 54 oral mTOR inhibitor 54 generation purine nucleoside 54 Taxotere ® 54 refractory APL 54 R sorafenib tablets 54 Genasense oblimersen sodium Injection 54 Phase 2a clinical 54 GORE VIABAHN Endoprosthesis 54 Fodosine 54 OZURDEX 54 RX ACCULINK 54 pediatric malignancies 54 Omacetaxine 54 PROCHYMAL 54 Protelos 54 ADI PEG 54 atacicept 54 calcineurin inhibitors 54 Phase IIa clinical 54 Tesetaxel 54 Mitoxantrone 54 TEMODAL 54 unique alkylating agent 54 fluoropyrimidine 54 Mobi C 54 Asentar 54 pivotal Phase III 54 Fleximer 54 photodynamic therapy PDT 54 Diabetic Macular Edema 54 brentuximab vedotin 54 Phase III ADT 54 CAPHOSOL 54 Serada 54 Phase 1b clinical 53 PNT# 53 SPIRIT FIRST 53 Bortezomib 53 oncology indications 53 acute ischemic stroke 53 PDX pralatrexate 53 eTag assays 53 Augment Injectable 53 rilonacept 53 MAA submission 53 Zenvia ™ 53 randomized controlled clinical 53 plus gemcitabine 53 Sirolimus eluting Coronary Stent 53 OMP #M# 53 Xcytrin R 53 trastuzumab 53 phase IIa 53 Sublative Rejuvenation 53 AEOL # 53 FIRMAGON R 53 vinorelbine 53 Prostate AdenoCarcinoma Treatment 53 Torisel 53 Bendavia 53 TAXUS Element Stent System 53 TBC# 53 XIENCE PRIME 53 cannabinor 53 Microwave Ablation System 53 investigational pan BCR 53 LibiGel Phase III 53 isavuconazole 53 phase IIb III 53 RE LY ® 53 Dual Opioid 53 IMiDs 53 octreotide 53 interferon gamma 1b 53 infusional 5-FU/LV 53 lubiprostone 53 virus HCV protease inhibitor 53 oral salmon calcitonin 53 Treanda 53 Chrysalin 53 tremelimumab 53 ACUROX ® 53 #D#C# 53 Oxaliplatin 53 AVADO 53 VeraTag 53 evaluating satraplatin 53 ranolazine 53 Vernakalant 53 radiofrequency ablation 53 #I TM# 53 AACR NCI EORTC 53 Phase Ib clinical 53 DAVANAT R 53 pitavastatin 53 antiangiogenic therapy 53 TNFerade TM 53 NSABP 53 Abiraterone 53 omacetaxine 53 OMP #R# 53 PolyActive ® 53 Investigational Device Exemption IDE 53 ALA PDT 53 icatibant 53 atrasentan 53 gemcitabine 53 MEPACT 53 IAP inhibitors 53 Mepact 53 Xelox 53 NXL# 53 heavily pretreated 53 medically inoperable 53 evaluating T DM1 53 balloon brachytherapy 53 bone metastases 53 CytoFab 53 MabThera rituximab 53 Combination REOLYSIN R 53 STRIDE PD 53 FFR guided treatment 53 trastuzumab Herceptin 53 plus dexamethasone 53 IORT 53 metastatic sarcoma 53 TEMSO 53 interventional therapies 53 TAXUS VI 53 GEM OS1 53 lapatinib 53 EXPAREL 53 Paclitaxel 53 Genasense ® oblimersen 53 intraoperative radiotherapy 53 panitumumab 53 PROVENGE sipuleucel T 53 tyrosine kinase inhibitor 53 ZD# [001] 53 PFO migraine 53 NEUVENGE 53 chemotherapeutic regimen 53 Neovasc Reducer 53 TREDAPTIVE 53 V Everolimus Eluting Coronary 53 Fibrin Pad 53 Coronary Stent 53 gefitinib 53 doxorubicin 53 Myotech CSS 53 recurrent glioblastoma multiforme 53 Squalamine 53 bioabsorbable stent 53 oral rivaroxaban 53 antitumor activity 53 Accelerated Partial Breast Irradiation 53 Zarnestra 53 Custom NX 53 RAV# 53 tipranavir 53 BENLYSTA ® 53 celgosivir 53 Endovascular System 53 seliciclib CYC# 53 MEK inhibitor 53 investigational therapies 53 Eribulin 53 systemic RNAi therapeutic 53 investigational monoclonal antibody 53 ongoing Phase IIIb 53 HRPC 53 TOCOSOL Paclitaxel 53 Civacir 53 SEPET TM 53 GLP toxicology studies 53 oncolytic virus 53 CUDC 53 direct thrombin inhibitor 53 resminostat 53 CLARITY study 53 Personalized Immunotherapy 53 kidney urologic 53 Virulizin R 53 Harry Palmin President 53 Tavocept 53 APTIVUS 53 PROLARIS 53 Genous 53 ticagrelor Brilinta 53 LUVENIQ 53 Breast Cancer Assay 53 dasatinib Sprycel 53 azficel T 53 tolerated dose MTD 53 Intravail R 53 ALN VSP Phase 53 relapsed MM 53 Clolar 53 ZEVALIN ® 53 cancer neuroendocrine tumor 53 metastatic colorectal cancer 53 CA9 SCAN 53 radiotherapy SBRT 53 randomized Phase 2b 53 TRISENOX 53 CardioBip 53 CVac 53 subcutaneous formulation 53 hematological cancers 53 pemetrexed 53 RhuDex ® 53 NEBIDO 53 everolimus 53 KRAS mutations occur 53 VIDAZA 53 Alair System 53 tolerability pharmacokinetics